These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7812944)
1. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Huang CY; Wilson MW; Lay LT; Chow CK; Robertson LW; Glauert HP Cancer Lett; 1994 Dec; 87(2):223-8. PubMed ID: 7812944 [TBL] [Abstract][Full Text] [Related]
2. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245 [TBL] [Abstract][Full Text] [Related]
3. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745 [TBL] [Abstract][Full Text] [Related]
4. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats. Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286 [TBL] [Abstract][Full Text] [Related]
5. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity. Nilakantan V; Spear BT; Glauert HP Free Radic Biol Med; 1998 Jun; 24(9):1430-6. PubMed ID: 9641260 [TBL] [Abstract][Full Text] [Related]
6. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators. Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488 [TBL] [Abstract][Full Text] [Related]
7. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats. Kim SC; Hong JT; Jang SJ; Kang WS; Yoo HS; Yun YP J Toxicol Sci; 1998 May; 23(2):113-9. PubMed ID: 9644651 [TBL] [Abstract][Full Text] [Related]
8. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver. Wilson MW; Leung LK; Hong JT; Glauert HP Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588 [No Abstract] [Full Text] [Related]
9. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y Cancer Lett; 1991 Apr; 57(1):55-60. PubMed ID: 2025879 [TBL] [Abstract][Full Text] [Related]
11. Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels. Sterchele PF; Vanden Heuvel JP; Davis JW; Shrago E; Knudsen J; Peterson RE Biochem Pharmacol; 1994 Aug; 48(5):955-66. PubMed ID: 8093108 [TBL] [Abstract][Full Text] [Related]
12. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes. Hong JT; Yun YP Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418 [TBL] [Abstract][Full Text] [Related]
13. Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium. Borges T; Glauert HP; Chen LC; Chow CK; Robertson LW Arch Toxicol; 1990; 64(1):26-30. PubMed ID: 2306190 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes. Hong JT; Glauert HP Toxicology; 1998 Nov; 131(2-3):99-107. PubMed ID: 9928625 [TBL] [Abstract][Full Text] [Related]
15. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat. Graham MJ; Winham MA; Old SL; Gray TJ Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300 [TBL] [Abstract][Full Text] [Related]
16. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats. Srinivasan SR; Chow CK; Glauert HP Toxicology; 1990 Jun; 62(3):321-32. PubMed ID: 2389247 [TBL] [Abstract][Full Text] [Related]
17. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats. Leung LK; Glauert HP Toxicology; 1998 Feb; 126(1):65-73. PubMed ID: 9585093 [TBL] [Abstract][Full Text] [Related]
18. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators. Glauert HP; Hong JT; Leung LK; Wilson MW Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604 [No Abstract] [Full Text] [Related]
19. Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of two-stage hepatocarcinogenesis in rats. Borges T; Peterson RE; Pitot HC; Robertson LW; Glauert HP Cancer Lett; 1993 Aug; 72(1-2):111-20. PubMed ID: 8104684 [TBL] [Abstract][Full Text] [Related]
20. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]